Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 258 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Balhara Yatan Pal Singh, Sarkar Siddharth, Gupta Rishab

Year : 2015| Volume: 19| Issue : 4 | Page no: 451-461

   This article has been cited by
1 Advantages of Phosphodiesterase Type 5 Inhibitors in the Management of Glucose Metabolism Disorders: A Clinical and Translational Issue
Cristina Antinozzi,Paolo Sgrò,Luigi Di Luigi
International Journal of Endocrinology. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
2 The treatment rate of erectile dysfunction (ED) in younger men with type 2 diabetes is up to four times higher than the equivalent non-diabetes population
Mike Stedman,Martin B. Whyte,Mark Lunt,Marco Albanese,Mark Livingston,Roger Gadsby,Geoff Hackett,Simon G. Anderson,Adrian H. Heald
International Journal of Clinical Practice. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review
A. Anand Ganapathy,V.M. Hari Priya,Alaganandam Kumaran
Journal of Ethnopharmacology. 2020; : 113536
[Pubmed]  [Google Scholar] [DOI]
4 LncRNA MALAT1 facilitates BM-MSCs differentiation into endothelial cells via targeting miR-206/VEGFA axis
Xiang Sun,Longhua Luo,Jiarui Li
Cell Cycle. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Effect of phosphodiesterase 5 inhibitors on blood pressure
Muhammad Ismail Shawish,Mohamed Ben-Eltriki,James M Wright
Cochrane Database of Systematic Reviews. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Undiagnosed prediabetes status is associated with a reduced effectiveness of phosphodiesterase type 5 inhibitors in men with erectile dysfunction
Luca Boeri,Paolo Capogrosso,Eugenio Ventimiglia,Edoardo Pozzi,Francesco Chierigo,Federico Belladelli,Rani Zuabi,Nicolò Schifano,Costantino Abbate,Federico Dehò,Emanuele Montanari,Francesco Montorsi,Andrea Salonia
International Journal of Impotence Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Interventions to Treat Erectile Dysfunction and Premature Ejaculation: An Overview of Systematic Reviews
Oana Ciocanel,Kevin Power,Ann Eriksen
Sexual Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
8 Les traitements oraux de la dysfonction érectile aujourd’hui, pour quel patient ?
M.H. Colson,B. Cuzin,A. Faix,L. Grellet,E. Huyghes
Sexologies. 2018; 27(1): 37
[Pubmed]  [Google Scholar] [DOI]
9 Sexual Dysfunction and Hypogonadism in Men With Diabetes
Richard Bebb,Adam Millar,Gerald Brock
Canadian Journal of Diabetes. 2018; 42: S228
[Pubmed]  [Google Scholar] [DOI]
10 Down-regulation of lncRNA MEG3 promotes endothelial differentiation of bone marrow derived mesenchymal stem cells in repairing erectile dysfunction
Xiang Sun,Long-hua Luo,Liang Feng,Dong-shui Li
Life Sciences. 2018; 208: 246
[Pubmed]  [Google Scholar] [DOI]
11 Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials
Xinyang Liao,Shi Qiu,Yige Bao,Wanyu Wang,Lu Yang,Qiang Wei
World Journal of Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
12 The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
F. Marampon,C. Antinozzi,C. Corinaldesi,G. B. Vannelli,E. Sarchielli,S. Migliaccio,L. Di Luigi,A. Lenzi,C. Crescioli
Endocrine. 2017;
[Pubmed]  [Google Scholar] [DOI]
13 Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Fatima Iqbal,Wendy S Baker,Madiha I Khan,Shwetha Thukuntla,Kevin H McKinney,Nicola Abate,Demidmaa Tuvdendorj
British Journal of Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 Sex and gender differences in therapy of type 2 diabetes
Alexandra Kautzky-Willer,Jürgen Harreiter
Diabetes Research and Clinical Practice. 2017;
[Pubmed]  [Google Scholar] [DOI]
15 First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis
G. Corona,G. Rastrelli,A. Burri,E. Serra,D. Gianfrilli,E. Mannucci,E. A. Jannini,M. Maggi
Andrology. 2016;
[Pubmed]  [Google Scholar] [DOI]
16 Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Thiago Pereira,Fabio Pimenta,Marcella Porto,Marcelo Baldo,Bianca Campagnaro,Agata Gava,Silvana Meyrelles,Elisardo Vasquez
International Journal of Molecular Sciences. 2016; 17(8): 1273
[Pubmed]  [Google Scholar] [DOI]
17 Antioxidant Potential and Ability of Phloroglucinol to Decrease Formation of Advanced Glycation End Products Increase Efficacy of Sildenafil in Diabetes-Induced Sexual Dysfunction of Rats
Sumanta Kumar Goswami,Suma Kallahalli Gangadarappa,Manikanta Vishwanath,Rema Razdan,Rohitash Jamwal,Naini Bhadri,Mohammed Naseeruddin Inamdar
Sexual Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article